Diagnosis of cardiac disease in pediatric end-stage renal disease

Blanche M. Chavers, Craig A. Solid, Alan Sinaiko, Frank X. Daniels, Shu Cheng Chen, Allan J. Collins, Diane L. Frankenfield, Charles A. Herzog

Research output: Contribution to journalArticle

Abstract

Background. Cardiac disease is a significant cause of morbidity and mortality in children with end-stage renal disease (ESRD). This study aimed to report the frequency of cardiac disease diagnostic methods used in US pediatric maintenance hemodialysis patients.Methods. A cross-sectional analysis of all US pediatric (ages 0.718 years, n = 656) maintenance hemodialysis patients was performed using data from the Centers for Medicare and Medicaid Services ESRD Clinical Performance Measures Project. Clinical and laboratory information was collected in 2001. Results were analysed by age, sex, race, Hispanic ethnicity, dialysis duration, body mass index (BMI), primary ESRD cause and laboratory data.Results. Ninety-two percent of the patients had a cardiovascular risk factor (63% hypertension, 38% anemia, 11% BMI > 94th percentile, 63% serum phosphorus > 5.5 mg/dL and 55% calciumphosphorus product <55 mg 2/dL2). A diagnosis of cardiac disease was reported in 24% (n = 155) of all patients: left ventricular hypertrophy/enlargement 17%, congestive heart failure/pulmonary edema 8%, cardiomyopathy 2% and decreased left ventricular function 2%. Thirty-one percent of patients were not tested. Of those tested, the diagnostic methods used were chest X-rays in 60%, echocardiograms in 35% and electrocardiograms in 33%; left ventricular hypertrophy/enlargement was diagnosed using echocardiogram (72%), chest X-ray (20%) and electrocardiogram (15%).Conclusions. Although 92% of patients had cardiovascular risk factors, an echocardiography was performed in only one-third of the patients. Our study raises the question of why echocardiography, considered the gold standard for cardiac disease diagnosis, has been infrequently used in pediatric maintenance dialysis patients, a high-risk patient population.

Original languageEnglish (US)
Pages (from-to)1640-1645
Number of pages6
JournalNephrology Dialysis Transplantation
Volume26
Issue number5
DOIs
StatePublished - May 2011

Fingerprint

Chronic Kidney Failure
Heart Diseases
Pediatrics
Maintenance
Left Ventricular Hypertrophy
Echocardiography
Renal Dialysis
Dialysis
Electrocardiography
Body Mass Index
Thorax
X-Rays
Centers for Medicare and Medicaid Services (U.S.)
Child Mortality
Pulmonary Edema
Cardiomyopathies
Left Ventricular Function
Hispanic Americans
Phosphorus
Anemia

Keywords

  • cardiac disease
  • end-stage renal disease
  • hypertension
  • maintenance hemodialysis
  • pediatric

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Chavers, B. M., Solid, C. A., Sinaiko, A., Daniels, F. X., Chen, S. C., Collins, A. J., ... Herzog, C. A. (2011). Diagnosis of cardiac disease in pediatric end-stage renal disease. Nephrology Dialysis Transplantation, 26(5), 1640-1645. https://doi.org/10.1093/ndt/gfq591

Diagnosis of cardiac disease in pediatric end-stage renal disease. / Chavers, Blanche M.; Solid, Craig A.; Sinaiko, Alan; Daniels, Frank X.; Chen, Shu Cheng; Collins, Allan J.; Frankenfield, Diane L.; Herzog, Charles A.

In: Nephrology Dialysis Transplantation, Vol. 26, No. 5, 05.2011, p. 1640-1645.

Research output: Contribution to journalArticle

Chavers, BM, Solid, CA, Sinaiko, A, Daniels, FX, Chen, SC, Collins, AJ, Frankenfield, DL & Herzog, CA 2011, 'Diagnosis of cardiac disease in pediatric end-stage renal disease', Nephrology Dialysis Transplantation, vol. 26, no. 5, pp. 1640-1645. https://doi.org/10.1093/ndt/gfq591
Chavers BM, Solid CA, Sinaiko A, Daniels FX, Chen SC, Collins AJ et al. Diagnosis of cardiac disease in pediatric end-stage renal disease. Nephrology Dialysis Transplantation. 2011 May;26(5):1640-1645. https://doi.org/10.1093/ndt/gfq591
Chavers, Blanche M. ; Solid, Craig A. ; Sinaiko, Alan ; Daniels, Frank X. ; Chen, Shu Cheng ; Collins, Allan J. ; Frankenfield, Diane L. ; Herzog, Charles A. / Diagnosis of cardiac disease in pediatric end-stage renal disease. In: Nephrology Dialysis Transplantation. 2011 ; Vol. 26, No. 5. pp. 1640-1645.
@article{5aeab362d81f48d5803793b09f0184d8,
title = "Diagnosis of cardiac disease in pediatric end-stage renal disease",
abstract = "Background. Cardiac disease is a significant cause of morbidity and mortality in children with end-stage renal disease (ESRD). This study aimed to report the frequency of cardiac disease diagnostic methods used in US pediatric maintenance hemodialysis patients.Methods. A cross-sectional analysis of all US pediatric (ages 0.718 years, n = 656) maintenance hemodialysis patients was performed using data from the Centers for Medicare and Medicaid Services ESRD Clinical Performance Measures Project. Clinical and laboratory information was collected in 2001. Results were analysed by age, sex, race, Hispanic ethnicity, dialysis duration, body mass index (BMI), primary ESRD cause and laboratory data.Results. Ninety-two percent of the patients had a cardiovascular risk factor (63{\%} hypertension, 38{\%} anemia, 11{\%} BMI > 94th percentile, 63{\%} serum phosphorus > 5.5 mg/dL and 55{\%} calciumphosphorus product <55 mg 2/dL2). A diagnosis of cardiac disease was reported in 24{\%} (n = 155) of all patients: left ventricular hypertrophy/enlargement 17{\%}, congestive heart failure/pulmonary edema 8{\%}, cardiomyopathy 2{\%} and decreased left ventricular function 2{\%}. Thirty-one percent of patients were not tested. Of those tested, the diagnostic methods used were chest X-rays in 60{\%}, echocardiograms in 35{\%} and electrocardiograms in 33{\%}; left ventricular hypertrophy/enlargement was diagnosed using echocardiogram (72{\%}), chest X-ray (20{\%}) and electrocardiogram (15{\%}).Conclusions. Although 92{\%} of patients had cardiovascular risk factors, an echocardiography was performed in only one-third of the patients. Our study raises the question of why echocardiography, considered the gold standard for cardiac disease diagnosis, has been infrequently used in pediatric maintenance dialysis patients, a high-risk patient population.",
keywords = "cardiac disease, end-stage renal disease, hypertension, maintenance hemodialysis, pediatric",
author = "Chavers, {Blanche M.} and Solid, {Craig A.} and Alan Sinaiko and Daniels, {Frank X.} and Chen, {Shu Cheng} and Collins, {Allan J.} and Frankenfield, {Diane L.} and Herzog, {Charles A.}",
year = "2011",
month = "5",
doi = "10.1093/ndt/gfq591",
language = "English (US)",
volume = "26",
pages = "1640--1645",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Diagnosis of cardiac disease in pediatric end-stage renal disease

AU - Chavers, Blanche M.

AU - Solid, Craig A.

AU - Sinaiko, Alan

AU - Daniels, Frank X.

AU - Chen, Shu Cheng

AU - Collins, Allan J.

AU - Frankenfield, Diane L.

AU - Herzog, Charles A.

PY - 2011/5

Y1 - 2011/5

N2 - Background. Cardiac disease is a significant cause of morbidity and mortality in children with end-stage renal disease (ESRD). This study aimed to report the frequency of cardiac disease diagnostic methods used in US pediatric maintenance hemodialysis patients.Methods. A cross-sectional analysis of all US pediatric (ages 0.718 years, n = 656) maintenance hemodialysis patients was performed using data from the Centers for Medicare and Medicaid Services ESRD Clinical Performance Measures Project. Clinical and laboratory information was collected in 2001. Results were analysed by age, sex, race, Hispanic ethnicity, dialysis duration, body mass index (BMI), primary ESRD cause and laboratory data.Results. Ninety-two percent of the patients had a cardiovascular risk factor (63% hypertension, 38% anemia, 11% BMI > 94th percentile, 63% serum phosphorus > 5.5 mg/dL and 55% calciumphosphorus product <55 mg 2/dL2). A diagnosis of cardiac disease was reported in 24% (n = 155) of all patients: left ventricular hypertrophy/enlargement 17%, congestive heart failure/pulmonary edema 8%, cardiomyopathy 2% and decreased left ventricular function 2%. Thirty-one percent of patients were not tested. Of those tested, the diagnostic methods used were chest X-rays in 60%, echocardiograms in 35% and electrocardiograms in 33%; left ventricular hypertrophy/enlargement was diagnosed using echocardiogram (72%), chest X-ray (20%) and electrocardiogram (15%).Conclusions. Although 92% of patients had cardiovascular risk factors, an echocardiography was performed in only one-third of the patients. Our study raises the question of why echocardiography, considered the gold standard for cardiac disease diagnosis, has been infrequently used in pediatric maintenance dialysis patients, a high-risk patient population.

AB - Background. Cardiac disease is a significant cause of morbidity and mortality in children with end-stage renal disease (ESRD). This study aimed to report the frequency of cardiac disease diagnostic methods used in US pediatric maintenance hemodialysis patients.Methods. A cross-sectional analysis of all US pediatric (ages 0.718 years, n = 656) maintenance hemodialysis patients was performed using data from the Centers for Medicare and Medicaid Services ESRD Clinical Performance Measures Project. Clinical and laboratory information was collected in 2001. Results were analysed by age, sex, race, Hispanic ethnicity, dialysis duration, body mass index (BMI), primary ESRD cause and laboratory data.Results. Ninety-two percent of the patients had a cardiovascular risk factor (63% hypertension, 38% anemia, 11% BMI > 94th percentile, 63% serum phosphorus > 5.5 mg/dL and 55% calciumphosphorus product <55 mg 2/dL2). A diagnosis of cardiac disease was reported in 24% (n = 155) of all patients: left ventricular hypertrophy/enlargement 17%, congestive heart failure/pulmonary edema 8%, cardiomyopathy 2% and decreased left ventricular function 2%. Thirty-one percent of patients were not tested. Of those tested, the diagnostic methods used were chest X-rays in 60%, echocardiograms in 35% and electrocardiograms in 33%; left ventricular hypertrophy/enlargement was diagnosed using echocardiogram (72%), chest X-ray (20%) and electrocardiogram (15%).Conclusions. Although 92% of patients had cardiovascular risk factors, an echocardiography was performed in only one-third of the patients. Our study raises the question of why echocardiography, considered the gold standard for cardiac disease diagnosis, has been infrequently used in pediatric maintenance dialysis patients, a high-risk patient population.

KW - cardiac disease

KW - end-stage renal disease

KW - hypertension

KW - maintenance hemodialysis

KW - pediatric

UR - http://www.scopus.com/inward/record.url?scp=79955575461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955575461&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfq591

DO - 10.1093/ndt/gfq591

M3 - Article

C2 - 20861193

AN - SCOPUS:79955575461

VL - 26

SP - 1640

EP - 1645

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 5

ER -